State Street SPDR S&P Emerging Markets ex-China ETF (XCNY) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
State Street SPDR S&P Emerging Markets ex-China ETF (XCNY) operates in the Financial Services sector, specifically the Asset Management industry, with a market capitalization near $6.5M, listed on NASDAQ, carrying a beta of 0.70 to the broader market. The State Street SPDR S&P Emerging Markets ex-China ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Emerging ex-China BMI (the "Index")The Index is a market capitalization-weighted index of large-, mid-, and small-cap emerging market companies that excludes companies domiciled in ChinaBy removing Chinese equities, XCNY may allow investors to manage their China risk exposure separately, while still seeking high growth and capital appreciation potential from emerging market economies public since 2024-09-05.
Max pain analysis shows the strike price where the most options expire worthless. No recent options activity for XCNY as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.